← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MATRIX LABS · Approved 2008-04-25

Drug application

FDA Application #

ANDA078883

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

Efavirenz

Active ingredients

EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MATRIX LABS

First approval

2008-04-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown